tiprankstipranks
Trending News
More News >

Matthew Barcus Profile - Chardan Capital Analyst

18 Followers
tipranks
Matthew Barcus

Matthew Barcus
Chardan Capital

Wall Street Analyst
#4,339 out of 10,109 Wall Street Analysts
#11,570 out of 42,308 experts

Success Rate

29%
12 out of 41 ratings made a profit

Average Return

+5.80%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Matthew Barcus's trades since 2022 and holding each position for 1 Year would result in 29.27% of your transactions generating a profit, with an average return of 5.8% per rating.

Stock Rating Distribution

50Ratings
90.00% Buy
10.00% Hold
0.00% Sell
Distribution of Matthew Barcus's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Immunovant, Inc.
(IMVT)
Rating:Buy
Date:Sep 29, 2022 - Sep 29, 2023
Return:+613.50%
The most profitable rating made by Matthew Barcus

Matthew Barcus's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Notable Labs
Jul 20, 2022
Hold
Downgraded
2Ratings
0%
-73.90%
ONCR
Oncorus
Nov 30, 2022
Hold
Downgraded
5Ratings
0%
-54.23%
Purple Biotech
Feb 09, 2023
Buy
Reiterated
$11.00
(1186.85% Upside)
3Ratings
0%
-48.37%
VINC
Vincerx Pharma Inc
Feb 17, 2023
Hold
Assigned
5Ratings
25%
-33.83%
AMTI
Applied Molecular Transport
Mar 28, 2023
Hold
Downgraded
2Ratings
0%
-70.30%
Anixa Biosciences
Apr 18, 2023
Buy
Reiterated
$9.00
(101.79% Upside)
3Ratings
0%
-15.33%
Adverum Biotechnologies
May 04, 2023
Hold
Reiterated
1Ratings
0.00%
Q32 Bio
May 11, 2023
Buy
Reiterated
$126.00
(4911.14% Upside)
5Ratings
20%
-35.46%
Immunovant
May 22, 2023
Buy
Reiterated
$32.00
(40.54% Upside)
5Ratings
100%
+219.66%
Xilio Therapeutics
May 30, 2023
Buy
Reiterated
$7.00
(829.61% Upside)
3Ratings
0%
-68.20%
List of latest recommendations made by Matthew Barcus. Click to expand and see Matthew Barcus's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Matthew Barcus activity FAQ

What is the performance of Matthew Barcus's recommendations?
The percentage of profitable recommendations made by Matthew Barcus is 29%, and the average return per transaction is 5.80%.
    What stocks does Matthew Barcus cover?
    Matthew Barcus mostly covers QURE ,IMVT ,QTTB stocks.
      What was Matthew Barcus's most profitable rating?
      Matthew Barcus’s most profitable ratings was a buy on IMVT stock on Sep 29, 2022 - Sep 29, 2023. The return on the trade was +613.50%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here